Clinical practice. Plantar fasciitis.
Rachelle Buchbinder
https://pubmed.ncbi.nlm.nih.gov/15152061/Actively Recruiting
Led by University of Pennsylvania · Updated on 2025-10-10
62
Participants Needed
1
Research Sites
19 weeks
Total Duration
This research aims to compare two methods of corticosteroid injection for treating proximal plantar fasciitis, a condition causing heel and arch pain, especially when first stepping after rest. The study evaluates the effectiveness of ultrasound-guided injection versus anatomic topography-guided injection in relieving pain. Secondary goals include assessing foot-related quality of life and changes in plantar fascia thickness over time. Participants will be randomly assigned to receive either an anatomically guided injection or an ultrasound-guided injection. Both groups will receive injections containing bupivacaine, dexamethasone, and triamcinolone acetonide. The anatomical group will have the injection guided by palpation and a sham ultrasound device, while the ultrasound group will receive the injection with real ultrasound guidance in a radiology setting. Both approaches use a medial plantar approach and include preparation and dressing of the injection site. During the study, participants will have their pain assessed using a visual analog scale at baseline and at 3, 6, 9, and 12 months after injection. Foot function and quality of life will be evaluated using the Foot Function Index and Bristol Foot Score over the same time points. Ultrasound will also be used to measure plantar fascia thickness before and after treatment in the ultrasound group. The study includes double-blind randomization and aims to monitor safety and outcomes over a year of follow-up.
CONDITIONS
Plantar Fasciitis Randomized Clinical Control Trial
D
Donald S Malay, DPM
H
Hye R Kim, DPM
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Pennsylvania
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | US-guided steroid injection (USGI) | Anatomical-guided steroid injection (ATGI) |
|---|---|---|
| What it is | A steroid injection precisely delivered to the plantar heel under real-time ultrasound guidance. | A steroid injection administered to the plantar heel using anatomical landmarks without ultrasound imaging. |
| Role in trial | Investigational intervention arm assessing exact pain and function outcomes. | Comparator intervention arm representing standard anatomical injection. |
| Primary use | Delivers corticosteroids for targeted relief of heel pain and improvement in foot function in plantar fasciitis. | Delivers corticosteroids using anatomical landmarks for pain reduction and improved foot function in plantar fasciitis. |
| How it is given or performed | A diagnostic ultrasound machine is used to guide the needle for precise steroid injection into the fascia. | The injection is performed using physical palpation and anatomical reference points, with no ultrasound machine employed. |
| Evidence status | Ultrasound-guided corticosteroid injection has been shown in controlled studies and meta-analyses to improve pain and foot function in plantar fasciitis, with more accurate delivery than palpation-guided injection. | Anatomical-guided corticosteroid injection improves pain and function for plantar fasciitis, though outcomes depend on delivery accuracy. Studies compare efficacy against ultrasound-guidance. |
| Important limitations | Requires ultrasound equipment and trained personnel, which may increase procedure cost and limit accessibility. Long-term outcomes beyond 12 months remain limited. | Accuracy of injection may vary with practitioner skill and anatomical variability, potentially affecting efficacy. Delivery without imaging may miss optimal target. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single treatment session
Participants receive a single corticosteroid injection into the plantar heel, either guided by ultrasound or by anatomical landmarks, to treat plantar fasciitis.
1 injection visit (in-person)
Duration - 12 months
Participants attend follow-up visits to monitor pain relief and foot function, and to assess plantar fascia thickness using ultrasound over the course of one year.
Follow-up visits at 3, 6, 9, and 12 months (in-person)
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Rachelle Buchbinder
https://pubmed.ncbi.nlm.nih.gov/15152061/E Budiman-Mak, K J Conrad, K E Roach
https://pubmed.ncbi.nlm.nih.gov/2037861/Chien-Min Chen, Jenq-Shyong Chen, Wen-Chung Tsai...
https://pubmed.ncbi.nlm.nih.gov/23221670/Zonghuan Li, Chengyan Xia, Aixi Yu...
https://pubmed.ncbi.nlm.nih.gov/24658102/J Wessel
https://pubmed.ncbi.nlm.nih.gov/7481589/P E Bijur, W Silver, E J Gallagher
https://pubmed.ncbi.nlm.nih.gov/11733293/Wen-Chung Tsai, Chih-Chin Hsu, Carl P C Chen...
https://pubmed.ncbi.nlm.nih.gov/16353228/W C Tsai, C L Wang, F T Tang...
https://pubmed.ncbi.nlm.nih.gov/11030509/Sue Barnett, Rona Campbell, Ian Harvey
https://pubmed.ncbi.nlm.nih.gov/15901814/C C Young, D S Rutherford, M W Niedfeldt
https://pubmed.ncbi.nlm.nih.gov/11272297/University of Pennsylvania
Lead Sponsor